Aker Biomarine Withdraws Patent Lawsuit Against Rimfrost

0b087606-8c3b-4260-9437-c0a642791f6farticleimage.jpg

21 Apr 2017 --- Aker Biomarine has voluntarily withdrawn its complaint at the International Trade Commission (ITC), alleging that krill manufacturer Rimfrost had violated several of its patents.

Rimfrost owner, Stig Remøy welcomed the news and claimed that it shows that his company “has been right all along.”

“Aker Biomarine has no case, because you cannot patent nature itself,” he said.

Rimfrost has said that Aker Biomarine’s patent dispute with Rimfrost has had negative effects on the global krill market.

“We are observing that Aker Biomarine adopts harsh methods in an attempt to usurp a global krill monopoly,” Remøy says.

“This will not succeed, and cannot be accepted by us. When krill licenses were allocated in 2007, Norwegian authorities made it clear that it is in the nation's interest that licenses are distributed to multiple players.”

Remøy adds that as the ITC case closes, new market opportunities for Rimfrost are emerging.

“Rimfrost’s ambitions with krill are extensive,” Remøy says, “Our considerable krill oil capacities allow us to market worldwide.”

“In addition,” he says, “krill has major potential in the aquaculture market. Our technology increases growth and improves health for farmed salmon.”

Explaining the decision to drop the lawsuit, Katrin Berntsen, the Director Communication at Aker BioMarine told NutritionInsight that, “Since the ITC investigation started, Olympic Holding and Emerald Fisheries have gone bankrupt and their “Juvel” krill harvesting vessel has been seized by creditors.”

“Last week, we settled the patent dispute with Avoca. Considering these developments, Aker BioMarine has asked the ITC to discontinue its investigation.”

“Aker BioMarine will direct its resources used to maintain the ITC investigation to continue to pursue its claim for patent infringement and damages from Rimfrost and Bioriginal in the pending District Court case in Delaware.”

Berntsen added that, “The omega-3 market where we compete with our Superba ingredient has been soft.”

“In this competitive market, in order to drive growth, we have invested in market innovation and science that can drive demand in new market segments.”

Related Articles

Nutrition & Health News

Chronic Fatigue Syndrome Linked to Imbalanced Microbiome

26 Apr 2017 --- Scientists have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome (IBS). The findings come from researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health.

Nutrition & Health News

SGS Approved to Audit Against the Gluten-Free Certification Organization Standard

26 Apr 2017 --- SGS, the world’s leading inspection, verification, testing and certification company has been approved as the first Certification Body to audit against the Gluten-Free Certification Organization (GFCO) standards covering all regions of the world.

Nutrition & Health News

Glanbia Introduces Lecithin-Free Agglomeration Technology

26 Apr 2017 --- Glanbia Nutritionals has announced a breakthrough patent-pending agglomeration technology called BevEdge for powdered drink mixes and liquid beverages. Entirely lecithin free, this method of agglomeration is based on an all-protein solution and can be applied to whey-based, milk-based, casein-based and plant-based ingredients, including hydrolysates. This flexibility provides both sports and lifestyle brands with significantly more opportunities to create highly marketable beverages. And with no lecithin, it is a perfect clean label solution.

Nutrition & Health News

Low Fat, High Sugar "Diet" Products Contribute to Weight Gain: US Study

26 Apr 2017 --- A new study has underscored the idea that low fat, high sugar "diet" foods play an important role in unwanted weight gain. Researchers from the University of Georgia found that rats fed a diet high in sugar but low in fat increased body fat mass when compared to rats fed a balanced (rodent) diet. Moreover, the rats fed a high-sugar diet were more likely to experience a range of other health problems, such as liver damage and brain inflammation.

Nutrition & Health News

Colitis Relieving Properties Turmeric Extract BCM-95 Underlined by Study

26 Apr 2017 --- A study has found that while standard curcumin does possess anti-inflammatory properties, BCM-95, a high-potency turmeric extract, is significantly more effective than standard curcumin in reducing colitis related disease activity and inflammatory symptoms. BCM-95 is a proprietary formulation of Arjuna Natural Extracts in a joint venture with Dolcas Biotech LLC and is composed of pure curcuminoids and essential oils from turmeric with a specific content of turmerones.

More Articles
URL : http://www.nutritioninsight.com:80/news/aker-biomarine-withdraws-patent-lawsuit-against-rimfrost.html